Polymorphous light eruption

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 3, 2002, Pages 193-206

  Stratigos, A J ^a   Antoniou, C ^a   Katsambas, A D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Photoprovocation; Photosensitivity; Phototesting; Phototherapy; Polymorphous light eruption; psoralen + ultraviolet A; Ultraviolet A; Ultraviolet B; Ultraviolet radiation

Indexed keywords

ALPHA TOCOPHEROL; ANTIGEN; ANTIMALARIAL AGENT; ANTIOXIDANT; AZATHIOPRINE; BETA CAROTENE; CHLOROQUINE; CORTICOSTEROID; FERULIC ACID; FISH OIL; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOXSALEN; NICOTINAMIDE; OMEGA 3 FATTY ACID; PLACEBO; PREDNISOLONE; PREDNISONE; STEROID; SUNSCREEN;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DERMIS; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; EPIDERMIS; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; LIGHT EXPOSURE; MALE; PAPULE; PATHOGENESIS; PHOTOCHEMOTHERAPY; PHOTODERMATOSIS; PHOTOSENSITIVITY DISORDER; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PRURITUS; PUVA; RADIATION EXPOSURE; RADIATION PROTECTION; RADIOSENSITIVITY; SKIN EDEMA; SKIN MANIFESTATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; DIFFERENTIAL DIAGNOSIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMAN; PHOTOSENSITIVITY DISORDERS; ULTRAVIOLET RAYS; HUMANS;

EID: 0035996140     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00443.x     Document Type: Article

References (113)

1. Om et polymorft (erythematost, vesikulost og ekzematoidt) lysudslet
2. Studier over Lysdermatirene. II. Undersogesler over pathologiske Sera's Virkning paa fotodermiske Processer
3. Epidemiological studies of the influence of sunlight on the skin
4. Polymorphous light eruption: A common reaction uncommonly recognised
5. Current aspects of polymorphous light eruptions in Sweden
6. Polymorphic light eruption: Prevalence in Australia and England
7. Polymorphous light eruption
8. Light sensitive eruptions in American Indians
9. Polymorphous light eruption
10. The idiopathic photodermatoses
11. The natural history of polymorphous light eruptions
12. Heredity of chronic polymorphous light eruptions
13. Hereditary polymorphous light eruption in Canadian Inuit
14. HLA typing in actinic prurigo
15. HLA typing in polymorphous light eruption
16. Lucite polymorphe et perturbation du metabolisme du tryptophane (voie de la cynurenine)
17. Treatment of polymorphous light eruption with nicotinamide: A pilot study
18. Polymorphous light eruption and oral contraceptives
19. Eicosanoid release in polymorphous light eruption; Selective UV-A-induced LTB4 generation by peripheral blood leucocytes
20. The heritability of polymorphous light eruption
21. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo
22. HLA-DR4 may determine expression of actinic prurigo in British patients
23. Polymorphous light eruption
24. An evaluation of sunscreens in patients with broad spectrum photosensitivity
25. The erythemal response to ultraviolet radiation in subjects with polymorphic light eruption
26. Erythermal and pigmentary phototest reactions in polymorphous light eruption
27. Testing of the skin for reactions to ultraviolet radiation
28. Polymorphic light eruption. Experimental reproduction of skin lesions
29. Light tests and pathogenetic wavelengths in chronic polymorphous light dermatosis
30. Phototoxicity, photoallergy, and photoskin tests
31. Polymorphous light eruption
32. The action spectrum in polymorphic light eruption
33. Studies with a monochromator in the common idiopathic photodermatoses
34. Polymorphous light eruption
35. Polymorphous light eruptions: Wavelength dependency and energy studies
36. Polymorphous light eruption. Action spectrum and photoprotection
37. Der PDL-Patient. Hauttyp, Hardening und andere Licht-assoziierte Merkmale
38. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruptions: A retrospective study of 133 patients
39. Experimentally induced reactions to ultraviolet light. Polymorphous light eruption and phototoxicity to drugs
40. Polymorphous light eruption. Phototest technique studies
41. Polymorphous light eruption: Successful reproduction of skin lesions, including papulovesicular light eruption, with ultraviolet B
42. Polymorphous light eruption: A clinical, photobiologic, and follow-up study of 110 patients
43. Polymorphous light eruption in hypopigmented pressure areas with a UVA sunbed
44. Polymorphous light eruption: Eliciting and inhibiting wavelengths
45. Dose response and time course for induction of T6-DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation
46. Studies in abnormal human sensitivity to light. IV. Photoallergic concept of prurigo aestivalis
47. Photoallergic contact dermatitis from Fentichlor
48. Heat shock proteins and the immune response
49. 65 kilodalton heat shock protein expression in experimentally induced polymorphic light eruption
50. A study on cell-mediated immunity in polymorphous light eruption
51. Immuno-pathology of polymorphous light eruption
52. PUVA photosensitization in polymorphous light eruption: Evaluation of systemic immunological factors
53. Immune sensitization against epidermal antigens in polymorphous light eruption
54. Polymorphic light eruption: An immunopathological study of evolving lesions
55. Role of interferon-? in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events
56. Expression of endothelial adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) in the evolution of cutaneous inflammation: A comparison of ultraviolet B (UVB) erythema and delayed-type hypersensitivity (DTH)
57. Adhesion molecule expression in polymorphic light eruption
58. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption
59. The role of interleukins 1,6, and 8 as lymphocyte attractants in the photodermatoses polymorphic light eruption and chronic actinic dermatitis
60. Study of the apoptosis phenomenon in patients suffering from chronic polymorphous light eruption and comparison of the phenomenon with normal subjects
61. Augmentation of ultraviolet erythema by indomethacin in actinic prurigo. Evidence of mechanism of photosensitivity
62. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to photoprovocation of polymorphic light eruption
63. Polymorphous light eruption
64. The idiopathic photodermatoses: Polymorphic light eruption, actinic prurigo, and hydroa vacciniforme
65. Photodermatitis multiformis acuta
66. Der PDL-Patient
67. Polymorphic light eruption limited to areas of vitiligo
68. Polymorphic light eruption occurring solely on an area of nevoid telangiectasia
69. Papulovesicular light eruption. A defined subset of polymorphous light eruption
70. Polymorphic light eruption sine eruptione
71. Psoralen plus ultraviolet A in the prophylactic treatment of benign summer light eruption
72. Juvenile spring eruption of the ears. A re-examination
73. Polymorphous light eruption
74. Histopathologic findings in papulovesicular light eruption
75. Papular polymorphic eruption: An immunoperoxidase study using monoclonal antibodies
76. Papular polymorphous light eruption. Fibrin, complement, and immunoglobulin deposition
77. Action spectra of lupus erythematosus and experimental immunofluorescence
78. Polychromatic phototest as a prognostic tool for polymorphic light eruption
79. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation
80. Polymorphous light eruption
81. The occurrence of antinuclear, anti-SSA/Ro and anti-SSB/La antibodies in patients with polymorphous light eruption
82. Polymorphous light eruption. A seven year follow up evaluation of 114 patients
83. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption
84. Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. A forme fruste of photosensitive lupus erythematosus?
85. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings
86. The cutaneous porphyrias: A review
87. The clinical and photophotobiological characteristics of solar urticaria in 40 patients
88. Actinic prurigo and polymorphic light eruption: Common pathogenesis and the importance of HLA-DR4/DRB1*0407
89. Disease associations in polymorphous light eruption. A long term follow-up study of 94 patients
90. Contact allergy to sunscreen chemicals in photosensitivity dermatitis/actinic reticuloid syndrome (PD/AR) and polymorphic light eruption (PLE)
91. Occurrence of polymorphous light eruption in lupus erythematosus
92. Polymorphic light eruption with contact and photocontact dermatitis
93. Treatment of polymorphic light eruption
94. Psoralen photochemotherapy - Mechanisms, drugs, toxicity
95. Prophylactic PUVA and UVB therapy in polymorphous light eruption: A controlled trial
96. UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria
97. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption
98. Short course of PUVA therapy is effective in polymorphic light eruption
99. Artificial hardening for polymorphic light eruption: Practical points from ten years' experience
100. Guidelines for PUVA
101. Treatment of polymorphous light eruption with PUVA and prednisolone
102. Assessment of the efficacy of a short course of oral prednisolone in the treatment of polymorphous light eruption
103. Efficacy of short-course oral prednisolone in polymorphous light eruption: A randomized controlled trial
104. Successful treatment of severe polymorphous eruption with azathioprine
105. Controlled therapeutic trials in polymorphic light eruption
106. Hydroxychloroquine in polymorphic light eruption: A controlled trial with drug and visual sensitivity monitoring
107. Effect of nicotinamide on the phototest reaction in polymorphous light eruption
108. Treatment of polymorphous light eruptions with beta-carotene
109. Oral carotenoid treatment in polymorphous light eruption: A cross over comparison with oxychloroquine and placebo
110. Effects of topically applied antioxidants in experimentally provoked polymorphous light eruption
111. Polymorphic light eruption occurring in common variable hypogammaglobulinaemia, and resolving with intravenous immunoglobulin therapy